Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 386.68M | $ 2.41M | $ 0 | $ 0 | -0.62% |
3/31/2025 | $ 188.38M | $ 3.84M | $ 0 | $ 0 | -2.04% |
12/31/2024 | $ 224.28M | $ 4.31M | $ 0 | $ 0 | -1.92% |
9/30/2024 | $ 693.33M | $ 3.42M | $ 0 | $ 0 | -0.49% |
6/30/2024 | $ 443.47M | $ 2.45M | $ 0 | $ 0 | -0.55% |
3/31/2024 | $ 755.22M | $ 688K | $ 0 | $ 0 | -0.09% |
12/31/2023 | $ 731.08M | $ 100K | $ 0 | $ 0 | -0.01% |
9/30/2023 | $ 212.87M | $ 0 | $ 0 | $ 0 | 0% |
6/30/2023 | $ 268.7M | $ 52K | $ 0 | $ 0 | -0.02% |
3/31/2023 | $ 295.7M | $ 52K | $ 0 | $ 0 | -0.02% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for Y-MABS THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 135.29M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.97B ]
(=) Shareholder Yield [ -6.86% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |